scholarly journals Optimal light for greenhouse culture of American ginseng seedlings

2017 ◽  
Vol 41 (3) ◽  
pp. 370-372
Author(s):  
John T.A. Proctor ◽  
John W. Palmer
2003 ◽  
Vol 64 (1) ◽  
pp. 257-264 ◽  
Author(s):  
Robert W. Nicol ◽  
Lina Yousef ◽  
James A. Traquair ◽  
Mark A. Bernards

2014 ◽  
Vol 99 ◽  
pp. 8-15 ◽  
Author(s):  
Chunhao Yu ◽  
Chong-Zhi Wang ◽  
Chun-Jie Zhou ◽  
Bin Wang ◽  
Lide Han ◽  
...  

2021 ◽  
Vol 103 ◽  
pp. 50-59
Author(s):  
Hanlei Yue ◽  
Chunying Liu ◽  
Yuting Han ◽  
Ziyu Zhuang ◽  
Hongshan Yu ◽  
...  
Keyword(s):  

PPAR Research ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Guoyu Wu ◽  
Junyang Yi ◽  
Ling Liu ◽  
Pengcheng Wang ◽  
Zhijie Zhang ◽  
...  

PPARγis a nuclear hormone receptor that functions as a master regulator of adipocyte differentiation and development. Full PPARγagonists, such as the thiazolidinediones (TZDs), have been widely used to treat type 2 diabetes. However, they are characterized by undesirable side effects due to their strong agonist activities. Pseudoginsenoside F11 (p-F11) is an ocotillol-type ginsenoside isolated fromPanax quinquefolium L.(American ginseng). In this study, we found that p-F11 activates PPARγwith modest adipogenic activity. In addition, p-F11 promotes adiponectin oligomerization and secretion in 3T3-L1 adipocytes. We also found that p-F11 inhibits obesity-linked phosphorylation of PPARγat Ser-273 by Cdk5. Therefore, p-F11 is a novel partial PPARγagonist, which might have the potential to be developed as a new PPARγ-targeted therapeutics for type 2 diabetes.


Sign in / Sign up

Export Citation Format

Share Document